Akslen LA - Search Results

1

Molecular assessment of depth of myometrial invasion in stage I endometrial cancer: a model based on K-ras mutation analysis.

Alexander-Sefre F, Salvesen HB, Ryan A, Singh N, Akslen LA, MacDonald N, Wilbanks G, Jacobs IJ. Alexander-Sefre F, et al. Among authors: akslen la. Gynecol Oncol. 2003 Oct;91(1):218-25. doi: 10.1016/s0090-8258(03)00505-5. Gynecol Oncol. 2003. PMID: 14529685

2

Frequency and prognostic impact of microsatellite instability in a large population-based study of endometrial carcinomas.

MacDonald ND, Salvesen HB, Ryan A, Iversen OE, Akslen LA, Jacobs IJ. MacDonald ND, et al. Among authors: akslen la. Cancer Res. 2000 Mar 15;60(6):1750-2. Cancer Res. 2000. PMID: 10749149

3

Molecular differences between RER+ and RER- sporadic endometrial carcinomas in a large population-based series.

Macdonald ND, Salvesen HB, Ryan A, Malatos S, Stefansson I, Iversen OE, Akslen LA, Das S, Jacobs IJ. Macdonald ND, et al. Among authors: akslen la. Int J Gynecol Cancer. 2004 Sep-Oct;14(5):957-65. doi: 10.1111/j.1048-891X.2004.014535.x. Int J Gynecol Cancer. 2004. PMID: 15361209

4

Molecular pathogenesis and prognostic factors in endometrial carcinoma.

Salvesen HB, Akslen LA. Salvesen HB, et al. Among authors: akslen la. APMIS. 2002 Oct;110(10):673-89. doi: 10.1034/j.1600-0463.2002.1101001.x. APMIS. 2002. PMID: 12583434 Review.

5

Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer.

Stefansson IM, Salvesen HB, Akslen LA. Stefansson IM, et al. Among authors: akslen la. J Clin Oncol. 2004 Apr 1;22(7):1242-52. doi: 10.1200/JCO.2004.09.034. J Clin Oncol. 2004. PMID: 15051772

6

Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression.

Salvesen HB, Stefansson I, Kretzschmar EI, Gruber P, MacDonald ND, Ryan A, Jacobs IJ, Akslen LA, Das S. Salvesen HB, et al. Among authors: akslen la. Int J Oncol. 2004 Dec;25(6):1615-23. Int J Oncol. 2004. PMID: 15547698

7

Plasma calprotectin concentrations in women with endometrial carcinoma.

Ni Bhriain H, Trovik J, Wik E, Stefansson IM, Akslen LA, Salvesen HB, Staff AC. Ni Bhriain H, et al. Among authors: akslen la. Gynecol Oncol. 2009 Sep;114(3):491-5. doi: 10.1016/j.ygyno.2009.06.008. Epub 2009 Jul 3. Gynecol Oncol. 2009. PMID: 19577278

8

Biologic markers in endometrial cancer treatment.

Engelsen IB, Akslen LA, Salvesen HB. Engelsen IB, et al. Among authors: akslen la. APMIS. 2009 Oct;117(10):693-707. doi: 10.1111/j.1600-0463.2009.02467.x. APMIS. 2009. PMID: 19775337 Review.

9

High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma.

Garcia-Dios DA, Lambrechts D, Coenegrachts L, Vandenput I, Capoen A, Webb PM, Ferguson K; ANECS; Akslen LA, Claes B, Vergote I, Moerman P, Van Robays J, Marcickiewicz J, Salvesen HB, Spurdle AB, Amant F. Garcia-Dios DA, et al. Among authors: akslen la. Gynecol Oncol. 2013 Feb;128(2):327-34. doi: 10.1016/j.ygyno.2012.11.037. Epub 2012 Dec 4. Gynecol Oncol. 2013. PMID: 23219661

10

Expression of glucocorticoid receptor is associated with aggressive primary endometrial cancer and increases from primary to metastatic lesions.

Tangen IL, Veneris JT, Halle MK, Werner HM, Trovik J, Akslen LA, Salvesen HB, Conzen SD, Fleming GF, Krakstad C. Tangen IL, et al. Among authors: akslen la. Gynecol Oncol. 2017 Dec;147(3):672-677. doi: 10.1016/j.ygyno.2017.09.013. Epub 2017 Sep 18. Gynecol Oncol. 2017. PMID: 28927900

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

377 results

Search Page

Filters